Showing results (61-70 of 739) with videos related to
Sort By:
Pageof 74
Atherosclerosis|August 1, 1995
DNA polymorphisms of the apoprotein B gene are associated with altered plasma lipoprotein concentrations but not with perceived risk of cardiovascular disease: European Atherosclerosis Research StudyP R Turner, P J Talmud, S Visvikis, et al.Annals of Human Genetics|June 28, 2001
Interaction of the common apolipoprotein C-III (APOC3 -482C > T) and hepatic lipase (LIPC -514C > T) promoter variants affects glucose tolerance in young adults. European Atherosclerosis Research Study II (EARS-II)H Jansen, D M Waterworth, V Nicaud, et al.Clinical Chemistry|November 30, 2006
Candidate gene genotypes, along with conventional risk factor assessment, improve estimation of coronary heart disease risk in healthy UK menSteve E Humphries, Jackie A Cooper, Philippa J Talmud, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|April 29, 1998
Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides: the European Atherosclerosis Research Study (EARS)S E Humphries, V Nicaud, J Margalef, et al.QJM : Monthly Journal of the Association of Physicians|September 1, 1996
Genetic factors affecting the consistency and magnitude of changes in plasma cholesterol in response to dietary challengeS E Humphries, P J Talmud, C Cox, et al.The Journal of Biological Chemistry|June 9, 2005
Determination of the functionality of common APOA5 polymorphismsPhilippa J Talmud, Jutta Palmen, Wendy Putt, et al.Current Opinion in Chemical Biology|September 28, 2000
Mechanisms of DNA replicationM J Davey, M O'DonnellJournal of Paediatrics and Child Health|December 21, 2012
Sleep disorders in infants and childrenHarriet Hiscock, Margot J DaveyJournal of Gerontological Social Work|July 16, 2014
Grannies, elders, and friends: aging Aboriginal women in TorontoCyndy Baskin, Caitlin J DaveyPharmacoeconomics|August 18, 2000
The cost effectiveness of misoprostol prophylaxis alongside long-term nonsteroidal anti-inflammatory drugs. Implications of the MUCOSA trialP J Davey, E MeyerPageof 74